Browsing by Author Ackland, Stephen

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2017Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04)Ansari, Nabila; Solomon, Michael; Ackland, Stephen; Burmeister, Bryan; Fisher, Richard; Heriot, Alexander; Joseph, David; Mackay, John; McClure, Bev; McLachlan, Sue-Anne; Ngan, Samuel; Medicine; Central Clinical School: SurgeryAcute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04), Annals of Surgery, vol.265, 5, 2017,pp 882-888
2011Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast CancerCoates, Alan; Gebski, Val; Grimison, Peter; Stockler, Martin; Wilcken, Nicholas; Zannino, Diana; Ackland, Stephen; Byrne, Michael J.; Fitzharris, B; Fong, A.; Forbes, John; Francis, Prudence; Gainford, Corona; Harvey, V; Nowak, Anna; Paksec, Lisa; Simes, John; Sourjina, Tatiana; Van Hazel, Guy; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); School of Public Health: NH&MRC Clinical Trials CentreCapecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer, Journal of Clinical Oncology, vol.29, 34, 2011,pp 4498-4504
2016Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trialBack, Michael; Khasraw, Mustafa; Lee, Adrian; Wheeler, Helen; Ackland, Stephen; Buyse, Marc E.; Kerestes, Z; Kichenadasse, G; McCowatt, Sally; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; Northern Clinical School: MedicineCilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial, Journal of Neuro-Oncology, vol.128, 1, 2016,pp 163-171
2016Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trialBack, Michael; Khasraw, Mustafa; Lee, Adrian; Wheeler, Helen; Ackland, Stephen; Buyse, Marc E.; Kerestes, Z; Kichenadasse, G; McCowatt, Sally; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; Northern Clinical School: MedicineCilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial, Journal of Neuro-Oncology, vol.128, 1, 2016,pp 163-171
2016The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04)Solomon, Michael; Ackland, Stephen; Burmeister, Bryan H.; Fisher, Richard; Goldstein, David; Leong, Trevor; Mackay, John; McClure, Bev; McKendrick, Joseph; McLachlan, Sue Anne; Ngan, S. Y.; Zalcberg, John; Central Clinical School: SurgeryThe impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04), European Journal of Cancer, vol.55, N/A, 2016,pp 15-26
2005A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer.Abdi, Ehtesham; Ackland, Stephen; Dhillon, Haryana; Jones, Michael; Simes, Robert John; Yuen, Jennifer; Goldberg, R M; Moore, M J; Sargeant, A.; Shepherd, L.; Tu, D.; School of Public Health: Public Health; Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreA meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer., British Journal of Cancer, vol.93,(11),2005,pp 1236-1243
2011A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancerAckland, Stephen; Boyle, Frances; Coates, Alan; Friedlander, Michael; Gebski, Val; Hudson, Malcolm; Lee, Chee; Lord, Sarah (Sally); Simes, Robert John; Stockler, Martin; School of Public Health: NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreA nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer, Breast Cancer Research and Treatment, vol.129, 2, 2011,pp 467-476
2012Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04Solomon, Michael; Ackland, Stephen; Burmeister, Bryan H.; Fisher, Richard; Goldstein, D; Hartopeanu, Chris; Joseph, David; Leong, T.; Mackay, John; McClure, Bev; McKendrick, J; McLachlan, Sue Anne; Ngan, S. Y.; Schache, David; Zalcberg, John; Central Clinical School: SurgeryRandomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04, Journal of Clinical Oncology, vol.30, 31, 2012,pp 3827-3833
2005Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.Ackland, Stephen; Fitzgerald, Lara; Gebski, Val; Joseph, D; Simes, Robert John; Walpole, Euan; Burmeister, Bryan H.; Devitt, Peter G.; et, al; Gotley, David C.; Millar, Jeremy L.; North, John; Smithers, Bernard Mark; Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Surgery; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreSurgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial., Lancet Oncology, vol.6,(9),2005,pp 659-668